Table 1 Expression of SNHG16 in various cancers

Acute lymphoblastic leukemia

up

37

up

MOLT3, MOLT4, SUP-B15, CCRF-CEM, RS4;11, TALL104, CEM/C1, CEM/C2, Loucy

BMMC

[22]

Bladder cancer

up

275

up

5637, J82, RT4, T24

SV-HUC-1

[23]

up

26

up

T24, RT4, 253 J-Bv

SV-HUC-1

[24]

up

46

up

T-24, BIU87, 5637

SV-HUC-1

[25]

up

40

up

5637, T24, J82

RT4

[26]

Breast cancer

up

30

–

MDA-MB-231, MCF-7, MDA-MB-468, HEK293T

–

[27]

Cervical cancer

up

38

up

SiHa, CaSki, HeLa, C33A

H8

[28]

up

66

up

SiHa, CaSki, HeLa, C33A, ME180

HcerEpic

[29]

Colorectal cancer

up

56

up

SW480, LoVo, CaCO-2 and HCT116

CCC-HIE-2

[30]

up

314

up

HCT116, SW480

–

[31]

down

81

down

LoVo, Caco-2, DLD1, SW620, SW480, HCT8, HCT116

CCC-HIE-2

[32]

Diffuse large B-cell lymphoma

up

48

up

OCI-LY7, OCI-LY3

B lymphocytes

[33]

Endometrial carcinoma

up

–

up

HEC-1B, HEC-1A, RL95–2, AN3CA

MEC

[34]

Esophageal squamous cell carcinoma

up

68

up

eca109, EC9706, TE1, kyse-30, kyse-70

HEEC

[35]

up

128

up

TE-13, TE-1, EC-1, Eca-109

HEEC

[36]

Gastric cancer

up

32

up

BGC823, MGC803, MKN45, SGC7901

GES-1

[37]

up

122

up

AGS, BGC-823, MGC-803, SGC-7901, MKN451

GES-1

[38]

up

20

up

HGC-27 and AGS

–

[39]

up

54

–

–

–

[40]

Glioma

up

48

up

U251, H4, SW1783, LN229

NHAs

[41]

up

40

up

U251, H4, SW1783, LN229

NIHAS

[42]

up

40

up

U251, LN229

NHA

[43]

Hepatocellular carcinoma

down

43

down

Hep3B, HuH7, SNU398, SNU423, SNU429, Hep3G2, SK-HEP-1, PLC/PRF/5

THLE2, THLE3

[44]

up

10

up

SK-Hep-1, Huh7, Hep3B, HepG2

HL-7702

[45]

up

34

up

Huh7, HepG2, SMMC7721, SK-Hep1, Hep 3B

LO2

[46]

up

47

up

MHCC97H, HuH7, SMMC7721, Hep3B, HepG2

LO2

[47]

up

40

up

HepG2, SMMC7721, Hep3B, Bel7402, Huh7

LO2

[48]

up

30

up

Huh7, HepG2, SMMC7721, QGY-7703

HL-7702

[49]

up

50

up

Hep-3B, Huh7, Sk-hep-1, SMMC-7721, PLC

HL-77O2

[50]

Neuroblastoma

up

48

up

SK-N-SH, IMR-32, SK-N-AS, SK-N-DZ

HUVEC

[51]

up

40

–

–

–

[52]

Non small cell lung cancer

up

66

up

A549, NCI-H292, NCI-H460, NCI-H1703

16HBE

[53]

up

30

up

A549, NCI-H292, NCI-H460, NCI-H1703

16HBE

[54]

Oral squamouscell carcinoma

up

29

up

SCC-25, CAL-27, Tca8113, TSCCA

NHOK

[55]

Osteosarcoma

up

25

up

U2OS, SaOS2

hFOB1.19

[56]

up

96

up

U2OS, Saos-2, HOS, MG-63

hFOB 1.19

[57]

up

20

up

MG-63, U2OS, SAOS2, HOS

OB3

[58]

up

65

–

U2OS, MG-63

–

[59]

Ovarian cancer

up

103

up

SKOV-3, ES2, HO8910, OMC685

IOSE-29

[60]

Pancreatic cancer

up

46

up

BxPC-3, SW1990, PANC-1, AsPC-1

HPDE6-C7

[61]

Papillary thyroid cancer

up

48

up

IHH-4, TPC-1, HTH83

Nthy-ori 3–1

[62]

Retinoblastoma

up

30

up

WERI Rb1, SO-RB-50, Y79

ARPE-19

[63]